Media Contact:
Nidhi Addanki
857-330-3629
nidhiaddanki@rational360.com
HSCA Comments on FDA Bulk Substance Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Food and Drug Administration (FDA) draft guidance on the use of bulk substances under Section 503B of the Federal Food, Drug, and Cosmetic Act. HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to...
Learn MoreHSCA Comments on DEA Proposed Rule on Opioid Production Limits
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration (DEA) proposed rule on annual opioid production limits.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as...
Learn MoreHSCA Announces Healthcare Cybersecurity Key Considerations
The Healthcare Supply Chain Association (HSCA) today announced the release of key cybersecurity considerations for healthcare providers, medical device manufacturers and service providers to help protect patient health, safety and privacy. In conjunction with the release of the key considerations, HSCA also published ‘Recommendations for Medical Device Cybersecurity Terms and Conditions,’...
Learn MoreHSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph., today released the following statement encouraging the Drug Enforcement Administration (DEA) to take critical steps to ease current shortages of injectable opioids:
“Hospitals and other healthcare providers are currently experiencing critical shortages of a number of injectable opioid medications – including...
Learn More